A phase II study (biov-121) of clofarabine monotherapy first line in patients aged 65 years or older with acute meyloid leukemia for whom standard intensive chemotherapy is not considered suitable

AK Burnett, M Baccarani, P Johnson, J Yin, A Saunders, N Russell, Robert Hills

Research output: Contribution to conference (unpublished)Abstract

Original languageEnglish
Publication statusPublished - 1 Jan 2006

Cite this